Skip to main content

Table 2 Unadjusted and adjusted Cox proportional hazard analysis for overall survival

From: Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

Overall survival          
  Unadjusted model
Overall cohort
Large adjusted model
Overall cohort
Simple adjusted model
Overall cohort
  HR 95% CI p HR 95% CI p HR 95% CI p
MCT1 1.622 1.030–2.554 0.037 2.123 1.145–3.937 0.017 1.963 1.199–3.214 0.007
Grade 4.684 1.715–12.79 0.003 3.210 1.136–9.076 0.028 3.797 1.372–10.50 0.010
Stage 2.288 1.500–3.489 <0.001 1.965 1.078–3.579 0.027 2.080 1.300–3.328 0.002
Size 1.269 0.585–2.750 0.547 0.681 0.306–1.515 0.346
LVSI 2.347 0.935–5.891 0.069 1.185 0.378–3.718 0.771
MI 1.447 0.609–3.436 0.403 1.121 0.340–3.690 0.851
  1. Grade categorised as Grade I/II and III tumours; Stage: FIGO 2009 stage categorised as 1, 2, 3 and 4; Size categorised as <2 cm, between 2 and 5 cm and bigger than 5 cm; LVSI: Lymphovascular space involvement categorised as “Yes” and “No”; MI: Depth of myometrial invasion categorised as <50% and more than 50%; HR: hazard ratio, CI: confidence interval. Bold text indicates statistically significant data at p < 0.05 level